Claim Missing Document
Check
Articles

Found 5 Documents
Search

The Effect Of Fig Supplementation On Nutritional Status And Immunity Of The Elderly: A Literature Review Rachmat Faisal Syamsu; Salsabila Tirta Aprilia; Mutiara Amalia
Jurnal EduHealth Vol. 15 No. 04 (2024): Jurnal EduHealt (inpres), Year 2024
Publisher : Sean Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Nutritional and immunity issues in the elderly are important issues that require serious attention, considering that as age increases, physiological changes occur that affect the nutritional status, health, and quality of life of the elderly. Factors such as reduced consumption of nutritious foods, decreased physical activity, and other health problems can increase the risk of malnutrition in the elderly. Figs ( Ficus carica ), which have long been known in traditional medicine, have been shown to have many health benefits, especially in improving the nutritional status and immunity of the elderly. The content of polyphenols, flavonoids, tannins , and other antioxidant compounds in figs has the ability to reduce oxidative stress, lower cholesterol levels, and increase endurance. Therefore, fig supplementation can be a good choice to support the health of the elderly, both in maintaining balanced nutrition and improving the body's immune system. Thus, figs are not only useful as a source of additional nutrition, but can also play a role in preventing or reducing various health problems that are often experienced by the elderly. As a medicinal plant, figs offer a more natural and economical alternative in supporting the welfare of the elderly, especially in improving the quality of life of those who are getting older.
A RELATIONSHIP BETWEEN THE HONEYCOMB APPEARANCE ON CT SCAN AND LIFE EXPECTANCY IN PATIENTS WITH SCLERODERMA? A SYSTEMATIC REVIEW Haekal Mahargias; Febrina Mayasari Gunawan; Mutiara Amalia
The Indonesian Journal of General Medicine Vol. 31 No. 1 (2026): The Indonesian Journal of General Medicine
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/mkxj5n20

Abstract

Introduction: Systemic sclerosis (SSc) is a complex autoimmune disease frequently complicated by interstitial lung disease (ILD), a leading cause of mortality. The honeycomb appearance on high-resolution computed tomography (HRCT) represents advanced pulmonary fibrosis, but its prognostic significance in SSc-ILD remains debated. This systematic review aims to evaluate the relationship between honeycomb appearance on CT scan and life expectancy in patients with scleroderma. Methods: A systematic review was conducted following PRISMA guidelines. We screened studies based on predefined criteria: confirmed SSc diagnosis, evaluation of honeycomb pattern on CT, reported survival outcomes, appropriate observational study design, adequate follow-up, and sufficient sample size (>10 patients). Data extraction encompassed study characteristics, CT methodology, honeycomb definition, survival outcomes, and statistical associations. Quality assessment and multivariate analyses were evaluated. Results: Among 198 included studies, sample sizes ranged from 10 to 62,930 patients, with follow-up periods from 12 months to over 20 years. Honeycombing prevalence in SSc-ILD cohorts ranged from 37.2% to 41.9%, with higher frequency in limited cutaneous SSc. Multiple studies demonstrated significant associations between honeycombing and mortality, with hazard ratios ranging from 1.72 (95% CI 1.38-2.14) to 4.64 (95% CI 1.68-12.81). The association persisted after adjusting for age, gender, pulmonary function tests, and scleroderma subtype. Automated quantitative CT methods (CALIPER) showed improved reproducibility compared to visual scoring. Discussion: This review provides robust evidence that honeycomb appearance on CT scan is an independent predictor of reduced life expectancy in SSc-ILD patients. Honeycombing represents irreversible fibrotic damage and consistently outperforms inflammatory features (ground-glass opacities) in prognostic value. Heterogeneity in honeycomb definitions and quantification methods remains a limitation. Conclusion: Honeycomb appearance on HRCT is a critical prognostic marker in SSc-ILD, associated with 2-3 fold increased mortality risk. Standardized CT reporting and incorporation of honeycombing into clinical risk stratification models are recommended. Future research should focus on automated quantitative assessment and validation of honeycombing-specific therapeutic algorithms.
CAN RADIOLOGICAL ASSESSMENT OF THE DEGREE OF CAROTID ARTERY STENOSIS BE USED AS AN INDEPENDENT PREDICTOR FOR THE RISK OF RECURRENT ISCHEMIC STROKE IN PATIENTS WITH PRIOR ISCHEMIC STROKE? A SYSTEMATIC REVIEW Haekal Mahargias; Febrina Mayasari Gunawan; Mutiara Amalia
The Indonesian Journal of General Medicine Vol. 13 No. 5 (2025): The Indonesian Journal of General Medicine
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/qy6f6v37

Abstract

Introduction: Recurrent ischemic stroke poses a significant clinical challenge, with carotid artery stenosis traditionally considered a major risk factor. However, whether the degree of stenosis alone independently predicts recurrence remains debated. This systematic review evaluates whether radiological assessment of carotid stenosis degree can serve as an independent predictor for recurrent ischemic stroke in patients with prior stroke. Methods: A systematic review was conducted following standardized screening criteria. Studies were included if they enrolled patients with confirmed prior ischemic stroke, assessed carotid stenosis using radiological methods (CT angiography, MR angiography, duplex ultrasound, or conventional angiography), quantified stenosis degree, and reported recurrent stroke outcomes. Data extraction encompassed study populations, stenosis assessment methods, recurrent stroke outcomes, multivariable analyses, and alternative predictors. Results: Fifty-nine studies were included, comprising 15 randomized controlled trials, 18 systematic reviews, and 26 cohort studies. The association between stenosis degree and recurrent stroke was heterogeneous. Large trials demonstrated significant independent prediction (POINT trial: OR 2.77, 95% CI 1.78-4.31; ENOS trial: OR 1.88, 95% CI 1.44-2.44 for ≥70% stenosis). However, other studies found no significant association (Mingyong Liu et al., 2014: annual risk 3.3% vs 4.7%, P=0.691; NAVIGATE-ESUS: HR 1.11, 95% CI 0.73-1.69). Plaque characteristics, particularly intraplaque hemorrhage, demonstrated stronger predictive value (HR 4.59-11.7) than stenosis degree alone. Cerebrovascular reserve also outperformed stenosis measurement (P=0.003 vs P=0.691). Recurrent events concentrated within the first 7-14 days post-index stroke (58% within 14 days), emphasizing the need for rapid risk stratification. Discussion: The predictive value of stenosis degree varies by clinical context, being most reliable in recently symptomatic severe (≥70%) stenosis but diminishing in moderate stenosis or when plaque vulnerability markers are considered. The pathophysiological basis for these findings relates to stenosis reflecting luminal narrowing without capturing plaque instability or hemodynamic compromise. Conclusion: Radiological assessment of carotid stenosis degree can serve as an independent predictor of recurrent ischemic stroke, but with moderate predictive accuracy (approximately 70%). Its clinical utility is enhanced when combined with plaque vulnerability markers, hemodynamic assessment, and consideration of timing from index event. Future risk stratification should integrate these multidimensional factors.
What Is The Association Between Pedal Access Intervention And Radiologically Measured Wound Healing Progression In Diabetic Foot Ulcers? : A Systematic Review Haekal Mahargias; Febrina Mayasari Gunawan; Mutiara Amalia
The International Journal of Medical Science and Health Research Vol. 33 No. 1 (2026): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/236cvp46

Abstract

Introduction: Diabetic foot ulcers (DFUs) represent a severe complication of diabetes, with peripheral artery disease (PAD) being a major contributor to poor healing and limb loss. Pedal access interventions, which target the small arteries of the foot, have emerged as a key revascularization strategy. However, the specific association between these procedures and radiologically measured wound healing progression requires systematic evaluation. This systematic review aims to synthesize the existing evidence on the association between pedal access interventions and radiologically assessed wound healing outcomes in patients with DFUs. Methods: A systematic review was conducted following a pre-defined protocol. We screened studies based on abstracts for inclusion criteria focusing on: (1) patients with diabetic foot ulcers, (2) pedal access interventions (angioplasty, stenting, bypass), (3) outcomes including radiologically measured wound healing, and (4) appropriate study designs (e.g., cohort studies, RCTs). Data were extracted on study characteristics, patient populations, intervention details, radiological assessment methods, wound healing outcomes, and the association between them. Results: From the screening of a large body of literature, data were extracted from numerous studies, many of which were observational cohorts. The patient populations were predominantly older males with long-standing diabetes and severe PAD. Pedal access interventions primarily involved endovascular techniques, such as angioplasty of tibial and pedal arteries, with some studies focusing on angiosome-guided or pedal arch revascularization (PAR). Radiological assessment methods varied, including duplex ultrasound (e.g., pedal acceleration time [PAT]), digital subtraction angiography (e.g., pedal arch patency), and plain radiographs (e.g., MAC scores). The synthesized evidence demonstrates a strong and consistent association between successful pedal access intervention and improved wound healing. Key findings show that a complete pedal arch (CPA) post-intervention is significantly associated with higher healing rates (e.g., 93.3% vs. 52.6% for an absent arch, p=0.003), shorter healing times (e.g., 3.5 vs. 5.7 months, p<0.001), and superior limb salvage (e.g., 100% vs. 68.4% at 1-year, p<0.001) (Troisi et al., 2018; Ismail et al., 2020). Similarly, successful PAR was associated with an 86.7% healing rate compared to 59.1% in unsuccessful cases (P=0.007) and dramatically lower major amputation rates (5.1% vs. 40.9%, p≤0.001) (Shahat et al., 2024; Jung et al., 2019). Angiosome-targeted revascularization also demonstrated superior healing outcomes compared to indirect revascularization (HR 1.97; 95% CI, 1.34-2.90) (Khor & Price, 2017; Söderström et al., 2013). Furthermore, novel non-invasive markers like PAT showed strong predictive value for wound healing (Sommerset et al., 2020; Karmy-Jones et al., 2024). Discussion: The findings robustly support the critical importance of restoring direct, pulsatile blood flow to the foot, specifically through the pedal arch and its branches, to facilitate DFU healing. The pedal arch acts as the crucial final vascular circuit, and its patency is a key determinant of healing and limb salvage. The discussion highlights that the quality of the revascularization outcome, particularly the establishment of a CPA, may be more important than the specific revascularization technique used. The integration of advanced radiological assessments like PAT offers a promising, non-invasive tool for patient selection and monitoring. Despite the strength of these associations, significant heterogeneity in study design, outcome measures, and radiological protocols exists, underscoring the need for more standardized approaches in future research. Conclusion: There is a definitive and positive association between successful pedal access intervention and radiologically measured wound healing progression in diabetic foot ulcers. Achieving a complete pedal arch and successful pedal arch revascularization are powerful predictors of superior outcomes, including faster healing, higher healing rates, and reduced amputation risk. These findings advocate for revascularization strategies that prioritize direct flow to the foot and the use of objective, non-invasive imaging to guide management.
How Effective is Chemoembolization (TACE) Compared to Standard Care on The Survival of Hepatoma Patients? A Systematic Review Haekal Mahargias; Febrina Mayasari Gunawan; Mutiara Amalia
The International Journal of Medical Science and Health Research Vol. 33 No. 2 (2026): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/nt123x81

Abstract

Introduction: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage HCC, but its effectiveness compared to evolving standard care modalities requires continuous evaluation. This systematic review aims to synthesize current evidence on the effectiveness of TACE versus standard care on the survival of hepatoma patients. Methods: A systematic review was conducted by screening a pre-defined set of literature. Studies were included if they compared TACE (as a primary treatment) to any form of standard care (e.g., supportive care, systemic therapy, other locoregional treatments) in HCC patients and reported survival outcomes. Data on study characteristics, patient populations, interventions, and outcomes (overall survival, progression-free survival, safety) were extracted and synthesized narratively. Results: The review included 200 studies, encompassing RCTs, meta-analyses, and cohort studies. TACE consistently demonstrated a significant survival benefit over best supportive care, with median overall survival extended from 3-7 months to 20-31 months in some studies (Biselli et al., 2005; Yuen et al., 2003). Compared to systemic monotherapy like sorafenib in advanced stages, TACE showed at least comparable outcomes (Pinter et al., 2012). While conventional TACE (cTACE) and drug-eluting bead TACE (DEB-TACE) showed mixed survival results, DEB-TACE was often associated with a better safety profile (Bzeizi et al., 2021; Chen et al., 2017). The most significant advancement was seen with combination therapies; TACE plus tyrosine kinase inhibitors and immunotherapies (e.g., LEAP-012, EMERALD-1) markedly improved progression-free survival (HR 0.66-0.77) compared to TACE alone (Kudo et al., 2025; Lencioni et al., 2024). Discussion: The evidence confirms TACE's role as a cornerstone of HCC treatment, particularly for intermediate-stage disease. Its effectiveness is maximized in patients with preserved liver function (Child-Pugh A) and low tumor burden. The field is shifting towards combination strategies, which offer superior tumor control but require careful management of increased toxicity. Major limitations include high heterogeneity in TACE protocols and control arm definitions across studies. Conclusion: TACE significantly improves survival compared to supportive care and remains a vital treatment for HCC. Emerging evidence strongly supports combining TACE with systemic therapies to enhance outcomes, establishing a new standard for many patients. Future research should focus on optimizing patient selection for these combination approaches.